JPMorgan downgrades Allient to Neutral and sets $120 price target
JPMorgan analyst Tomohiko Sano lowered Allient Inc.'s rating from Overweight to Neutral, citing a roughly 90% rally since May and an EV/EBITDA multiple of 25.7. The firm maintained a $120 price target based on 20.0 × fiscal‑year‑2027 estimated adjusted EBITDA and raised its third‑quarter and fourth‑quarter forecasts. The downgrade triggered an immediate 4% drop in the stock, which later recovered to $104.02, down 2.2% from the prior close.
Why it matters
The downgrade and high valuation concerns may pressure Allient's share price in the short term, while the $120 target provides a reference level for investors. JPMorgan’s raised forecasts suggest upside potential, but the rating change signals perceived downside risk.
Key facts
- 1JPMorgan downgraded Allient to Neutral from Overweight. investing.com
- 2The analyst set a price target of $120.00, based on 20.0 × fiscal‑year‑2027 estimated adjusted EBITDA. investing.com
- 3Allient shares had rallied approximately 90% since May. investing.com
- 4The stock trades at an EV/EBITDA of 25.7. investing.com
- 5JPMorgan raised its third‑quarter and fourth‑quarter forecasts for Allient. investing.com
- 6Allient shares fell about 4% after the downgrade, later rising to $104.02, down 2.2% from the previous close. financialcontent.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.